Ann L. Lee - 27 Feb 2025 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
Chief Technical Officer
Signature
/s/ Karen Brown, attorney-in-fact
Issuer symbol
PRME
Transactions as of
27 Feb 2025
Net transactions value
$0
Form type
4
Filing time
03 Mar 2025, 20:14:01 UTC
Previous filing
21 May 2024
Next filing
12 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRME Stock Option (right to buy) Award $0 +275,000 $0.000000 275,000 27 Feb 2025 Common Stock 275,000 $2.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 27, 2025, subject to the Reporting Person's continued service on each such vesting date.